Factors associated with gene mutation testing in United States veterans with metastatic castration-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Genitourinary Cancers ...
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results